Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

Aart Jan van der Lely, R Kent Hutson, Peter J Trainer, G Michael Besser, Ariel L Barkan, Laurence Katznelson, Anne Klibanski, Vivien Herman-Bonert, Shlomo Melmed, Mary Lee Vance, Pamela U Freda, Paul M Stewart, Keith E Friend, David R Clemmons, Gudmundur Johannsson, Stavros Stavrou, David M Cook, Lawrence S Phillips, Christian J Strasburger, Suzanne Hacker, Kenneth A Zib, Robert J Davis, John A Scarlett, Michael O Thorner

Open source

DOI: 10.1016/s0140-6736(01)06844-1
Published: 2001-11
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-01-06844-1,
  title = {Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist},
  author = {Aart Jan van der Lely and R Kent Hutson and Peter J Trainer and G Michael Besser and Ariel L Barkan and Laurence Katznelson and Anne Klibanski and Vivien Herman-Bonert and Shlomo Melmed and Mary Lee Vance and Pamela U Freda and Paul M Stewart and Keith E Friend and David R Clemmons and Gudmundur Johannsson and Stavros Stavrou and David M Cook and Lawrence S Phillips and Christian J Strasburger and Suzanne Hacker and Kenneth A Zib and Robert J Davis and John A Scarlett and Michael O Thorner},
  year = {2001},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(01)06844-1},
  url = {https://doi.org/10.1016/s0140-6736(01)06844-1}
}

RIS

TY  - JOUR
TI  - Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AU  - Aart Jan van der Lely
AU  - R Kent Hutson
AU  - Peter J Trainer
AU  - G Michael Besser
AU  - Ariel L Barkan
AU  - Laurence Katznelson
AU  - Anne Klibanski
AU  - Vivien Herman-Bonert
AU  - Shlomo Melmed
AU  - Mary Lee Vance
AU  - Pamela U Freda
AU  - Paul M Stewart
AU  - Keith E Friend
AU  - David R Clemmons
AU  - Gudmundur Johannsson
AU  - Stavros Stavrou
AU  - David M Cook
AU  - Lawrence S Phillips
AU  - Christian J Strasburger
AU  - Suzanne Hacker
AU  - Kenneth A Zib
AU  - Robert J Davis
AU  - John A Scarlett
AU  - Michael O Thorner
PY  - 2001
JO  - The Lancet
DO  - 10.1016/s0140-6736(01)06844-1
UR  - https://doi.org/10.1016/s0140-6736(01)06844-1
ER  -

APA

Lely, A. J. V. D., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., Freda, P. U., Stewart, P. M., Friend, K. E., Clemmons, D. R., Johannsson, G., Stavrou, S., Cook, D. M., Phillips, L. S., Strasburger, C. J., Hacker, S., Zib, K. A., Davis, R. J., Scarlett, J. A., & Thorner, M. O. (2001). Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. The Lancet. https://doi.org/10.1016/s0140-6736(01)06844-1

Source records

crossref · retrieved 2026-09-25T11:58:29.375Z